Ingegerd Hellström et al. found that HE4 was overexpressed in epithelial ovarian cancer in 2003, demonstrating for the first time that HE4 protein has potential as a biomarker for ovarian cancer [13]. Here, WFDC2 is linked to ovarian carcinoma.